Dashboard
Manage Tickers

AKLI


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

akili-says-endeavorotc-is-the-only-fda-authorized-digital-therapeutic-for-adhd-available-without-a-prescription
Akili Says EndeavorOTC Is The Only FDA-Aut...
06/18/2024 20:09:58

Delivered through an engaging video game experience, EndeavorOTC is indicated to improve attention function as measured by comp...

akili-reports-fda-clearance-of-endeavorotc-akl-t01-as-an-over-the-counter-treatment-for-adults-with-attention-deficithyperactivity-disorder
Akili Reports FDA Clearance Of EndeavorOTC...
06/18/2024 20:02:22

trading-halt-halt-status-updated-at-82500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:25:...
05/29/2024 12:25:04

Core News & Articles
PureTech Health Announces Merger Agreement...
05/29/2024 12:11:50

trading-halt-halted-at-75737-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:57:37 a.m. ET - ...
05/29/2024 11:57:41

akili-q1-2024-adj-eps-012-beats-014-estimate-sales-38300k-miss-79400k-estimate
Akili Q1 2024 Adj EPS $(0.12) Beats $(0.14...
05/14/2024 20:41:40

Akili (NASDAQ:AKLI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.2...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/14/2024 20:31:13

akili-evaluates-potential-strategic-alternatives
Akili Evaluates Potential Strategic Altern...
05/14/2024 20:24:43

gold-down-over-2-3m-profit-beats-expectations
Gold Down Over 2%; 3M Profit Beats Expecta...
04/30/2024 18:37:24

why-he-equipment-services-shares-are-trading-lower-by-around-18-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why H&E Equipment Services Shares Are Trad...
04/30/2024 17:24:09

nasdaq-dips-over-100-points-coca-cola-earnings-top-views
Nasdaq Dips Over 100 Points; Coca-Cola Ear...
04/30/2024 16:34:23

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 16:31:18

dow-tumbles-200-points-mcdonalds-posts-downbeat-earnings
Dow Tumbles 200 Points; McDonald's Posts D...
04/30/2024 14:17:54

akili-plans-to-continue-to-pursue-marketing-authorization-from--fda-of-endeavorotc-product
Akili Plans To Continue to Pursue Marketin...
04/30/2024 12:54:18

trading-halt-halt-status-updated-at-82500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:25:...
04/30/2024 12:25:04

akili-announces-companys-workforce-will-be-reduced-by-46-including-an-elimination-of-the-companys-marketing-and-medical-affairs-teams
Akili Announces Company's Workforce Will B...
04/30/2024 12:21:40

akili-announces-amended-agreement-with-shionogi-shionogi-has-canceled-and-forgiven-a-5m-long-term-debt-obligation-and-agreed-to-make-certain-payments-for-sdt-001-the-japanese-localized-version-of-akilis-akl-t01-digital-treatment-marketed-as-endeavorrx-in-the-us
Akili Announces Amended Agreement With Shi...
04/30/2024 12:21:36

Shionogi amendment provides Akili with near-term cash payments and cancellation of debt obligationCompany announces exploration...

trading-halt-halted-at-75500-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:55:00 a.m. ET - ...
04/30/2024 11:55:04

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
04/24/2024 20:31:44

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/12/2024 12:09:54

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION